Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER studyJosé M Álvaro-Gracia, Carlos Sanchez-Piedra, Dante Culqui, Rosa Rosello, Alicia Garcia-Dorta, Cristina Campos, Sara Manrique-Arija, Dolores Ruiz-Montesinos, Inmaculada Ros-Vilamajo, Carlos Rodríguez-Lozano, Mercedes Freire-González, Rafael Caliz, Cristina Bohorquez, Lourdes Mateo Soria, Noemí BusquetsSee the full list of authors
16 March 2023
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population studyXiaofeng Jiang, Jeffrey Sparks, Zachary Wallace, Xinjia Deng, Hui Li, Na Lu, Dongxing Xie, Yilun Wang, Chao Zeng, Guanghua Lei, Jie Wei, Yuqing Zhang
8 March 2023
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)Ai Phuong Tran, D.F Tassone, N S Ding, Johannes Nossent
2 March 2023
Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case seriesChathurika Lakmini Dandeniya, Theekshana Kavinda Premathilake
14 February 2023
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case seriesAlexander ten Hagen, Elisa Habermann, Sandra Hermann, Gerd R Burmester, Robert Biesen, Fredrik N. Albach
6 December 2022
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic diseaseLeonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander ten Hagen, Elisa Habermann, Florian Kurth, Leif Erik Sander, Victor Max Corman, Gerd-Rüdiger Burmester, Robert BiesenSee the full list of authors
6 December 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joe Sexton, Ingrid Egeland Christensen, Trung T Tran, Kristin Hammersbøen Bjørlykke, Siri Mjaaland, David J Warren, Tore K Kvien, Adity Chopra, Grete Birkeland Kro, Jorgen Jahnsen, Ludvig A Munthe, Espen A HaavardsholmSee the full list of authors
3 November 2022
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RAKristin Schmiedeberg, Irene A Abela, Natalia Barbara Pikor, Nicolas Vuilleumier, Magdalena Schwarzmueller, Selina Epp, Sabrina Pagano, Sarah Grabherr, Angelica Brooke Patterson, Madalina Nussberger, Alexandra Trkola, Burkhard Ludewig, Johannes von Kempis, Andrea Rubbert-Roth
26 October 2022
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccinationElisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif Erik Sander, Gerd R Burmester, Florian Klein, Robert Biesen
10 October 2022
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritisDavid Stahl, Carola tho Pesch, Carolin Brück, Ruth L Esser, Jan Thiele, Veronica Di Cristanziano, David M Kofler
10 October 2022
